- Abrams, S. (2012). Overview of Regulatory Myeloid Cells in Neoplasia Immunological Investigations41:555–561.
- Cohen, P. A., Ko, J. S., Storkus, W. J., Spencer, C. D., Bradley, J. M., Gorman, J. E., McCurry, D. B., Zorro-Manrique, S., Dominguez, A. L., Pathangey, L. B., (2012). Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape. Immunological Investigations 41:680–710.
- Haile, L., Greten, T., and Korangy, F. (2012). Immune suppression: the hallmark of myeloid-derived suppressor cells. Immunological Investigations 41:581–594.
- Harden, J., and Egilmez, N. (2012). Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunol Invest 41:
- Johnson, T., and Munn, D. H. (2012). Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance. Immunological Investigations 41:765–797.
- Kohanbash, G., and Okada, H. (2012). Myeloid-derived suppressor Cells (MDSCs) in gliomas and glioma-development. Immunological Investigations 41:658–679.
- Manjili, M. H. (2012). Phenotypic plasticity of MDSC in cancers. Immunological Investigations 41:711–721.
- Monu, N. R., and Frey, A. B. (2012). Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship. Immunological Investigations 41:595–613.
- Obermajer, N., Wong, J. L., Edwards, R. P., Odunsi, K., Moysich, K., and Kalinski, P. (2012). PGE2-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells. Immunological Investigations 41:635–657.
- Park Y-S, Bae J-H, Son CH, Lee K-S, Kim W, Jung MH, Yang K, Kim S-H, Kang C-D. (2011). Cyclophosphamide potentiates the antitumor effect of immunization with injection of immature dendritic cells into irradiated tumor. Immunological Investigations 40:383–99.
- Qu, P., Boelte, K. C., and Lin, P. C. (2012). Negative regulation of myeloid-derived suppressor cells in cancer. Immunological Investigations 41:562–580.
- Raber, P., Ochoa, A., and P., R. (2012). Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives. Immunological Investigations 41:614–634.
- Sawan S, Burt DJ, Stern PL, Holland C, Elkord E. (2011). Circulating regulatory T cells in endometrial cancer: a role for age and menopausal status. Immunological Investigations 40:62–75.
- Solito, S., Pinton, L., Damuzzo, V., and Mandruzzato, S. (2012). Highlights on molecular mechanisms of MDSC-mediated immune suppression: paving the way for new working hypotheses. Immunological Investigations 41:722–737.
- Todorova VK, Klimberg VS, Hennings L, Kieber-Emmons T, Pashov A. (2010). Immunomodulatory effects of radiofrequency ablation in a breast cancer model. Immunological Investigations 39:74–92.
- Wright SE, Rewers-Felkins KA, Quinlin IS, Phillips CA, Townsend M, Philip R, Zorsky P, Klug P, Dai L, Hussain M, Thomas AA, Sundaramurthy C. (2010). Number of treatment cycles influences development of cytotoxic T cells in metastatic breast cancer patients - a phase I/II study. Immunological Investigations 39:570–86.
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 41, 2012 - Issue 6-7